PRESS RELEASE
12 January 2021

Preparing For 2021: Drug And Device Pricing, Payment, And Fraud And Abuse Challenges

AP
Arnold & Porter

Contributor

Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
There were a variety of important legal and regulatory developments in the final months of 2020 that will impact pharmaceutical manufacturers in 2021 and beyond. This webinar will review some of these key developments in detail.
United States

Tuesday, January 12, 2021

12:00–2:00 PM ET

Arnold & Porter Webinar

Register

There were a variety of important legal and regulatory developments in the final months of 2020 that will impact pharmaceutical manufacturers in 2021 and beyond. This webinar will review some of these key developments in detail.

Topics

  • Value-based arrangements
  • Manufacturer product support programs
  • Manufacturer speaker programs
  • Healthcare technology
  • CMS Medicaid Rebate Program final rule
  • 340B Drug Pricing Program

Contributor

Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More